Maso Capital Partners LTD Moderna, Inc. Transaction History

Maso Capital Partners LTD

  • $84.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$65.74 - $169.86 $1.34 Million - $3.47 Million
-20,429 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$54.34 - $94.85 $295,011 - $514,940
5,429 Added 36.19%
20,429 $1.45 Million
Q2 2020

Aug 14, 2020
BUY
$29.67 - $80.0 $445,050 - $1.2 Million
15,000 New
15,000 $963,000

Others Institutions Holding MRNA

# of Institutions
940
Shares Held
240M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Maso Capital Partners LTD Portfolio

Follow Maso Capital Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maso Capital Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maso Capital Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email